Home » Topics » Conferences

Conferences
RSS

New 5-HT1A receptor antagonist from Astra Arcus undergoes extensive preclinical testing

Nov. 9, 1998

Neuroprotective agents with dual NOS-inhibitory and antioxidant effects synthesized at French lab

Nov. 9, 1998

NPS-2390: representative of a novel class of potent and selective group I mGluR antagonists

Nov. 9, 1998

Droloxifene effects on lipid parameters evaluated in healthy postmenopausal women

Nov. 9, 1998

In vitro and in vivo pharmacology of CP-465022 presented at neuroscience meeting

Nov. 9, 1998

Novel proteasome inhibitor effective in animal model of stroke

Nov. 9, 1998

APLAUD study evaluates SB-214857 in patients with coronary artery and cerebrovascular disease

Nov. 9, 1998

Effects of new free radical scavenger MDL-100002 in embolic stroke

Nov. 9, 1998

Centrally selective nAChR ligand from R.J. Reynolds considered Alzheimer's disease candidate

Nov. 9, 1998

Selective M2 receptor antagonist from Schering-Plough with potential in AD

Nov. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...